|
|
 |
|
Viewing report
|
|
|
|
Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets
Greystone Associates, May 2011
‘Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets’ is a comprehensive evaluation and analysis of the technology, products and participants behind the development programs and commercialization efforts in this evolving segment of the drug delivery sector.
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, indications, and commercial opportunities for drugs that can be delivered via the oral mucosa. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Evolving Technology and Patient-friendly Drug Delivery
In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism.
On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2015 as buccal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.
Feature Summary:
- Provides detailed analysis of transmucosal drug products, and assesses the prospects for development stage product candidates
- Analyzes demand drivers for transmucosally delivered drugs and evaluates the commercial potential for key indications.
- Analyzes technology factors, product development issues and market factors
- Provides market data and forecasts to 2015
- Profiles transmucosal drug delivery segment participants, their product development activities, business strategies, and corporate alliances and affiliations
- Evaluates the impact of economic and regulatory factors
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
